title: Sphingosine-1-phosphate-induced nociceptor excitation and ongoing pain behavior in mice and humans is largely mediated by S1P3 receptor.
abstract: The biolipid sphingosine-1-phosphate (S1P) is an essential modulator of innate immunity, cell migration, and wound healing. It is released locally upon acute tissue injury from endothelial cells and activated thrombocytes and, therefore, may give rise to acute post-traumatic pain sensation via a yet elusive molecular mechanism. We have used an interdisciplinary approach to address this question, and we find that intradermal injection of S1P induced significant licking and flinching behavior in wild-type mice and a dose-dependent flare reaction in human skin as a sign of acute activation of nociceptive nerve terminals. Notably, S1P evoked a small excitatory ionic current that resulted in nociceptor depolarization and action potential firing. This ionic current was preserved in "cation-free" solution and blocked by the nonspecific Cl(-) channel inhibitor niflumic acid and by preincubation with the G-protein inhibitor GDP-β-S. Notably, S1P(3) receptor was detected in virtually all neurons in human and mouse DRG. In line with this finding, S1P-induced neuronal responses and spontaneous pain behavior in vivo were substantially reduced in S1P(3)(-/-) mice, whereas in control S1P(1) floxed (S1P(1)(fl/fl)) mice and mice with a nociceptor-specific deletion of S1P(1)(-/-) receptor (SNS-S1P(1)(-/-)), neither the S1P-induced responses in vitro nor the S1P-evoked pain-like behavior was altered. Therefore, these findings indicate that S1P evokes significant nociception via G-protein-dependent activation of an excitatory Cl(-) conductance that is largely mediated by S1P(3) receptors present in nociceptors, and point to these receptors as valuable therapeutic targets for post-traumatic pain.
authors: Department of Physiology and Medical Physics, Division of Physiology, Medical University of Innsbruck, A-6020 Innsbruck, Austria. mcamprubi@umh.es
authors: María
authors: M
authors: Camprubí-Robles
authors: Norbert
authors: N
authors: Mair
authors: Manfred
authors: M
authors: Andratsch
authors: Camilla
authors: C
authors: Benetti
authors: Dimitra
authors: D
authors: Beroukas
authors: Roman
authors: R
authors: Rukwied
authors: Michiel
authors: M
authors: Langeslag
authors: Richard L
authors: RL
authors: Proia
authors: Martin
authors: M
authors: Schmelz
authors: Antonio V
authors: AV
authors: Ferrer Montiel
authors: Rainer V
authors: RV
authors: Haberberger
authors: Michaela
authors: M
authors: Kress
mesh_terms: D000328:Adult; D000818:Animals; D002478:Cells, Cultured; D004311:Double-Blind Method; D005260:Female; D005727:Ganglia, Spinal / Q000187:drug effects / Q000502:physiology; D006801:Humans; D008246:Lysophospholipids / Q000633:toxicity*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D010146:Pain / Q000139:chemically induced / Q000378:metabolism*; D010147:Pain Measurement / Q000187:drug effects / Q000379:methods*; D049349:Receptors, Lysosphingolipid / Q000502:physiology*; D013110:Sphingosine / Q000031:analogs & derivatives* / Q000633:toxicity
chemical_list: D008246:Lysophospholipids; D049349:Receptors, Lysosphingolipid; C060506:sphingosine 1-phosphate; D013110:Sphingosine
references: Pain. 2011 Mar;152(3):643-648
references: 21239112
references: Curr Drug Targets. 2007 Jan;8(1):155-67
references: 17266539
references: Anesthesiology. 2003 Oct;99(4):1023-7
references: 14508341
references: Proc Natl Acad Sci U S A. 2006 Oct 31;103(44):16394-9
references: 17050692
references: Mol Biol Cell. 2009 Nov;20(22):4664-72
references: 19776349
references: Biochim Biophys Acta. 2002 Dec 30;1585(2-3):193-201
references: 12531554
references: J Neurosci. 2010 Nov 17;30(46):15400-8
references: 21084596
references: Invest Ophthalmol Vis Sci. 2002 Oct;43(10):3202-8
references: 12356825
references: Arterioscler Thromb Vasc Biol. 2009 Oct;29(10):1439-43
references: 19592471
references: J Histochem Cytochem. 1998 Nov;46(11):1261-8
references: 9774625
references: Nat Protoc. 2007;2(6):1508-14
references: 17571058
references: Biochim Biophys Acta. 2006 Dec;1758(12):1978-94
references: 16843432
references: J Thromb Haemost. 2006 Dec;4(12):2704-9
references: 17010150
references: J Biol Chem. 2005 Apr 29;280(17):17320-8
references: 15728185
references: Trends Endocrinol Metab. 2007 Oct;18(8):300-7
references: 17904858
references: Mol Cell. 2002 Feb;9(2):229-31
references: 11864597
references: Curr Biol. 2001 Jan 23;11(2):121-4
references: 11231129
references: Neurology. 2011 Feb 22;76(8 Suppl 3):S9-14
references: 21339490
references: J Neurophysiol. 2006 Sep;96(3):1042-52
references: 16723416
references: Pharmacol Rev. 2008 Jun;60(2):181-95
references: 18552276
references: Naunyn Schmiedebergs Arch Pharmacol. 2007 Feb;374(5-6):413-28
references: 17242884
references: Wound Repair Regen. 2007 Sep-Oct;15(5):607-16
references: 17971005
references: J Physiol. 2006 Aug 15;575(Pt 1):101-13
references: 16740613
references: J Cell Biochem. 2004 Aug 1;92(5):882-99
references: 15258913
references: J Physiol. 1957 Feb 15;135(2):350-70
references: 13406745
references: J Thromb Haemost. 2011 Apr;9(4):790-8
references: 21251196
references: Biochem J. 2000 Jul 15;349(Pt 2):385-402
references: 10880336
references: Trends Neurosci. 2008 Jun;31(6):287-95
references: 18471901
references: J Neurophysiol. 2012 Aug 1;108(3):834-52
references: 22457464
references: Neurosci Lett. 1994 Mar 28;170(1):103-6
references: 8041482
references: Histochem Cell Biol. 2008 Oct;130(4):655-67
references: 18663462
references: J Invest Dermatol. 2003 Apr;120(4):693-700
references: 12648236
references: J Physiol. 2010 Sep 15;588(Pt 18):3365-73
references: 20498230
references: FASEB J. 2002 Oct;16(12):1497-503
references: 12374772
references: Nat Rev Mol Cell Biol. 2003 May;4(5):397-407
references: 12728273
references: EMBO J. 1996 Jan 2;15(1):63-72
references: 8598207
references: J Neurosci Methods. 1998 Aug 1;82(2):195-201
references: 9700692
references: Clin Exp Allergy. 2004 Mar;34(3):450-5
references: 15005740
references: Nature. 2008 Oct 30;455(7217):1210-5
references: 18724360
references: Mol Pain. 2008 Aug 12;4:32
references: 18700020
references: Acta Physiol Scand. 1986;128(Suppl. 554):221-33
references: 11649998
references: Trends Mol Med. 2007 May;13(5):210-7
references: 17416206
references: Prostaglandins Other Lipid Mediat. 2006 Dec;81(3-4):162-70
references: 17085324
references: Brain. 2005 Jul;128(Pt 7):1634-41
references: 15817518
references: Pain. 1988 Jan;32(1):77-88
references: 3340425
references: Neuroscience. 2003;118(1):69-74
references: 12676138
references: Mol Cell Biol. 2005 Dec;25(24):11113-21
references: 16314531
references: J Biol Chem. 2008 Nov 21;283(47):32442-51
references: 18805787
references: Am J Physiol Cell Physiol. 2011 Apr;300(4):C919-26
references: 21270296
references: Ann Clin Biochem. 2008 Jul;45(Pt 4):356-63
references: 18583619
references: Biochem J. 2000 Dec 15;352 Pt 3:809-15
references: 11104690
references: J Neurophysiol. 2010 Nov;104(5):2741-8
references: 20844107
references: PLoS One. 2011 Feb 17;6(2):e17268
references: 21359147
references: Cell. 1996 May 31;85(5):661-71
references: 8646775
references: J Biochem Mol Biol. 2006 Mar 31;39(2):113-31
references: 16584625
references: Acta Physiol (Oxf). 2012 Feb;204(2):227-37
references: 21624095
references: J Cell Sci. 2009 May 1;122(Pt 9):1322-33
references: 19351713
references: J Biol Chem. 2004 Jul 9;279(28):29367-73
references: 15138255
references: Blood. 2003 Nov 15;102(10):3665-7
references: 12869509
references: Biosci Rep. 1995 Oct;15(5):341-9
references: 8825036
references: Genesis. 2004 Mar;38(3):122-9
references: 15048809
references: Prostaglandins Other Lipid Mediat. 2008 Mar;85(3-4):107-14
references: 18166496
references: Nat Neurosci. 2012 May 27;15(7):1015-21
references: 22634729